Evaluation of the quality of guidelines for myasthenia gravis with the AGREE II instrument

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Zhang, Zhenchang ^a   Guo, Jia ^a   Su, Gang ^a   Li, Jiong ^a   Wu, Hua ^a   Xie, Xiaodong ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APPRAISAL OF GUIDELINES FOR RESEARCH AND EVALUATION II; ARTICLE; CHINA; COMPUTER PROGRAM; EMBASE; EVALUATION STUDY; EVIDENCE BASED PRACTICE; HUMAN; INFORMATION RETRIEVAL; MEDLINE; METHODOLOGY; MYASTHENIA GRAVIS; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRACTICE GUIDELINE; QUALITY CONTROL; SCORING SYSTEM; HEALTH CARE QUALITY; META ANALYSIS;

HUMANS; MYASTHENIA GRAVIS; PRACTICE GUIDELINES AS TOPIC; QUALITY OF HEALTH CARE;

EID: 84913573626     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111796     Document Type: Article

References (38)

1. Myasthenia Gravis Foundation of America. (2013) What is myasthenia gravis (MG)? Retrieved from http://www.myasthenia.org/WhatisMG.aspx.
2. Owe JF, Daltveit AK, Gilhus NE (2006) Causes of death among patients with myasthenia gravis in Norway between 1951 and 2001. J Neurol Neurosurg Psychiatry 77 (2): 203-207.
3. Grob D, Brunner N, Namba T, Pagala M (2008) Lifetime course of myasthenia gravis. Muscle Nerve 37 (2): 141-149.
4. Richman DP, Agius MA (2003) Treatment of autoimmune myasthenia gravis. Neurology 61 (12): 1652-1661.
5. Szajewska H, Hoekstra JH, Sandhu BK (2000) Management of acute gastroenteritis in Europe and the impact of new recommendations: A multicenter study. J Pediatr Gastroenterol Nutr 30 (5): 522-527.
6. Bezerra JA, Stathos TH, Duncan B, Gaines JA, Udall JN Jr (1992) Treatment of infants with acute diarrhoea: what's recommended and what's practiced. Pediatrics (1pt1); 90: 1-4.
7. Reis EC, Goepp JG, Katz S, Santosham M (1994) Barriers to the use of oral rehydration therapy. Pediatrics 93 (5): 708-711.
8. Hoekstra JH (2001) Acute gastroenteritis in industrialized countries: compliance with guidelines for treatment. J Pediatr Gastroenterol Nutr (Suppl 2): S31-S35.
9. Field MJ, Lohr KN (Eds) (1990) Clinical Practice Guidelines: Directions for a New Program, Institute of Medicine, Washington, DC: National Academy Press.
10. Lo Vecchio A, Giannattasio A, Duggan C, De Masi S, Ortisi MT, et al. (2011) Evaluation of the Quality of Guidelines for Acute Gastroenteritis in Children With the AGREE Instrument. J Pediatr Gastroenterol Nutr 52 (2): 183-189.
11. Grol R, Cluzeau FA, Burgers JS (2003) Clinical practice guidelines: towards better quality guidelines and increased international collaboration. Br J Cancer (Suppl. 1): S4-S8.
12. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, et al. (2010) AGREE Next Steps Consortium. AGREE II: Advancing guideline development, reporting, and evaluation in healthcare. CMAJ 182 (18): E839-E842.
13. Zhang ZW, Liu XW, Xu BC, Wang SY, Li L, et al. (2013) Analysis of Quality of Clinical Practice Guidelines for Otorhinolaryngology in China. PLoS ONE 8 (1): e53566.
14. Burda BU, Norris SL, Holmer HK, Ogden LA, Smith ME (2011) Quality varies across clinical practice guidelines for mammography screening in women aged 40-49 years as assessed by AGREE and AMSTAR instruments. J Clinical Epidemiol 64 (9): 968-976.
15. Burgers JS, Fervers B, Haugh M, Brouwers M, Browman G, et al. (2004) International assessment of the quality of clinical practice guidelines in oncology using the Appraisal of Guidelines and Research and Evaluation Instrument. J Clin Oncol 22 (10): 2000-2007. http://www.ncbi.nlm.nih.gov/pubmed?term=Philip%20T%5bAuthor%5d&cauthor=true&cauthor-uid=15143093.
16. Chen YL, Yao L, Xiao XJ, Wang Q, Wang ZH, et al. (2012) Quality assessment of clinical guidelines in China: 1993-2010. Chinese Medical Journal 125 (20): 3660-3664.
17. Xie LM, Wang WY (2012) A brief introduction to Appraisal of Guidelines for Research and Evaluation II J. Journal of Chinese Integrative Medicine 10 (2): 160-165.
18. Marinos CD (1999) Intravenous innunoglobulin in the Treatment of Autoimmune Neuromuscular Diseases: Present Status and Practical Therapeutic Guidelines. Muscle Nerve 22 (11): 1479-1497.
19. Donofrio PD, Berger A, Brannagan TH 3rd, Bromberg MB, Howard JF, et al. (2009) Consensus statements: The Use of Intravenous innunoglobulin in the Treatment of Neuromuscular Conditions Report of the AANEM AD HOC Committee. Muscle Nerve 40 (5): 890-900.
20. Benatar M, Sanders DB, Burns TM, Cutter GR, Guptill JT, et al. (2012) Recommendations for Myasthenia Gravis Clinical Trials. Muscle Nerve 45 (6), 909-917.
21. Adekanye O, Dugani S, Wilkes AR, Srinivas K, Hodzovic I (2009) AAGBI guidelines on the use of neuromuscular blockade monitoring. Anaesthesia 64 (8): 915-924.
22. Benatar M, Kaminski HJ, Quality Standards Subcommittee of the American Academy of Neurology (2007) Evidence report: The medical treatment of ocular myasthenia (an evidence-based review). Neurology 68 (24): 2144-2149.
23. The neurology branch of Chinese medical association neural immune group, China's nerve immunology branch of immunology (2011) Diagnosis and treatment of myasthenia gravis expert consensus in China. Chin J Neuroimmunology Neurol 5 (18): 368-372.
24. Immunology nerve immunology branch in China (2012) Diagnosis and treatment of myasthenia gravis, a China expert consensus. Chin J Neuroimmunology Neurol, 2012, 6 (19): 401-408.
25. Gronseth GS, Barohn RJ (2000) Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 55 (1): 7-15.
26. Elovaara I, Apostolski S, van-Doorn P, Gilhus NE, Hietaharju A, et al. (2008) EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases. Eur J Neurol 15 (9): 893-908.
27. Skeie GO, Apostolski S, Evoli A, Gilhus NE, Illa I, et al. (2010) Guidelines for treatment of autoimmune neuromuscular transmission disorders. Eur J Neurol 17 (7): 893-902. http://www.ncbi.nlm.nih.gov/pubmed?term=Harms%20L%5bAuthor%5d&cauthor=true&cauthor-uid=20402760.
28. Cortese I, Chaudhry V, So YT, Cantor F, Cornblath DR, et al. (2011) Evidencebased guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 76 (3): 294-300.
29. Patwa HS, Chaudhry V, Katzberg H, Rae-Grant AD, So YT (2012) Evidencebased guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 78 (13): 1009-1015.
30. AAEM Quality Assurance Committee, American Association of Electrodiagnostic Medicine (2001) Practice parameter for repetitive nerve stimulation and single fiber EMG evaluation of adults with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome: summary statement. Muscle Nerve 24 (9): 1236-1238.
31. Feasby T, Banwell B, Benstead T, Bril V, Brouwers M, et al. (2007) Guidelines on the use of intravenous immune globulin for neurologic conditions. Transfus Med Rev 21 (2 Suppl 1): S57-S107.
32. Skeie GO, Apostolski S, Evoli A, Gilhus NE, Hart IK, et al. (2006) Guidelines for the use of intravenous immunoglobulin in the treatment of neurologic diseases. Eur J Neurol 13 (7): 691-699.
33. Willison HJ, Ang W, Gilhus NE, Graus F, Liblau R, et al. (2000) EFNS task force report: A questionnaire-based survey on the service provision and quality assurance for determination of diagnostic autoantibody tests in European neuroimmunology centres. European Federation of Neurological Societies. Eur J Neurol 7 (6): 625-628.
34. Bascic-Kes V, Kes P, Zavoreo I, Lisak M, Zadro L, et al. (2012) Guidelines for the use of intravenous immunoglobulin in the treatment of neurologic diseases. Acta Clin Croat 51 (4): 673-683.
35. Alonso-Coello P, Irfan A, SolaI, Gich I, Delgado-Noguera M, et al. (2010) The quality of clinical practice guidelines over the last two decades: A systematic review of guideline appraisal studies. Qual Saf Health Care 19 (6): e58.
36. Knai C, Brusamento S, Legido-Quigley H, Saliba V, Panteli D, et al. (2012) Systematic review of the methodological quality of clinical guideline development for the management of chronic disease in Europe. Health Policy 107 (2-3): 157-167.
37. Huang TW, Lai JH, Wu MY, Chen SL, Wu CH, et al. (2013) Systematic review of clinical practice guidelines in the diagnosis and management of thyroid nodules and cancer. BMC Medicine 11: 191.
38. Simone B, De-Feo E, Nicolotti N, Ricciardi W, Boccia S (2012) Methodological quality of English-language genetic guidelines on hereditary breast-cancer screening and management: An evaluation using the AGREE instrument. BMC Medicine 10: 143.